Adaptation of the "Assessment of Adherence to Antiretroviral Therapy Questionnaire" ("Cuestionario de Evaluación de la Adhesión al Tratamiento antirretroviral" - CEAT-VIH) for its use in Peru;Adaptación del "Cuestionario de Evaluación de la Adhesión al Tratamiento antirretroviral" (CEAT-VIH) para su uso en Perú

Ars Pharmaceutica

Volumn 49, Issue 3, 2008, Pages 183-198

  Tafur Valderrama, E ^a   Ortiz, C ^d   Alfaro, C O ^b   Garcia Jimenez E ^c   Faus, M J ^c  

^a Centro Médico Naval cirujano Mayor   (Peru)

^b BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^c UNIVERSITY OF GRANADA   (Spain)

^d NONE

Author keywords

Adherence; Adherence questionnaire; Antiretroviral therapy; Compliance; Validation

Indexed keywords

ADULT; AGED; ASSESSMENT OF ADHERENCE TO ANTIRETROVIRAL THERAPY QUESTIONNAIRE; CLINICAL ARTICLE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; MALE; PATIENT COMPLIANCE; PERU; PSYCHOMETRY; QUESTIONNAIRE; RELIABILITY; REVIEW; VALIDATION PROCESS;

EID: 58949088862     PISSN: 00042927     EISSN: 00042927     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Grupo de Investigación en Atención Farmacéutica (CTS-131). Tercer Consenso de Granada sobre Problemas Relacionados con Medicamentos (PRM) y Resultados Negativos asociados a la Medicación (RNM). Ars Pharmaceutica 2007; 48(1):5-17
2. OGE - MINSA. Situación del VIH/SIDA en el Perú. Boletín Epidemiológico Mensual Diciembre 2007. Disponible en: http://www.oge.sld.pe/vigilancia/vih/Boletin-2007/diciembre.pdf. Con acceso enero 2008.
3. Ministerio de Salud-Perú. Norma técnica para el Tratamiento Antirretroviral de Gran Actividad-TARGA en adultos infectados por el virus de la inmunodeficiencia humana. Nt No124-2004-MINS/DGSP-V.01
4. Ido K. Role of pharmacists in medical team on HIV infection. Yakugaku Zasshi. 2006;126(6):409-14
5. Mannheimer S, Friedland G, Matts J, Child C, Chesney. The Consistency of Adherence to Antiretroviral Therapy Predicts Biologic Outcomes for Human Immunodeficiency Virus-Infected Persons in Clinical Trials. Clin Infect Dis 2002; 34:1115-21
6. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990; 47(3):533-543
7. Mac Keigan L, Pathak D. Overview of health-related quality-of-life measures. Am J Hosp Pharm 1992;49:2236-2244
8. Machuca M, Fernández-Llimós F, Faus MJ. Guía de seguimiento farmacoterapéutico. Grupo de Investigación en Atención Farmacéutica (CTS-131). Universidad de Granada. 2003
9. Codina C, Tuset M, Ibarra O, Delgado O, Morancho O, García B, Grupo VIH de la SEFH. Evaluación de un Programa de Atención Farmacéutica dirigido a mejorar la Adherencia al Tratamiento Antirretroviral. Farm Hosp (Madrid) 2004; 28 (Supl 1):19-26
10. Sandí J, Arias L. Impacto de la inducción farmacéutica sobre la adherencia de pacientes VIH/SIDA con tratamiento antirretroviral en el Hospital San Juan de Dios (Costa Rica). Seguim Farmacoter 2003; 1(2): 43-48.
11. Foisy M. Pharmaceutical Care for HIV Patients on Directly Observed Therapy. Ann Pharmacother 2000: 38 (4):550-556
12. Rudorf D, Krikorian S. Adverse Effects Associated With Antiretroviral Therapy and Potential Management Strategies. J Pharm Pract 2005; 18(4): 258-277
13. Ventura J, Alós M. Programa de atención farmacéutica a pacientes VIH con tratamiento antirretroviral: metodología y documentación. Farm Hosp (Madrid). 2004; 28.(Supl. 1): 72-79.
14. Paton N, Chapman C, Chan S, Tan K, Leo Y, Aboulhab J, Soh C. Validation of the Medical Outcomes Study HIV Health Survey as a measure of quality of life in HIV infected patients in Singapure. Int J STD & AIDS 2002;13:456-461
15. Kitahata M, Reed SD, Dillingham PW, Van Rompaey SE, Young AA, Harrington RD, Holmes KK. Pharmacy-based assessment of adherence to HAART predicts virologic and immunologic treatment response and clinical progression to AIDS and death. Int J STD AIDS. 2004 Dec;15(12):803-10.
16. Wood E, Hogg R, Yip B, Harrigan R, O'Shaughnessy M, Montaner J. The Impact of Adherence on CD4 Cell Count Responses Among HIV-Infected Patients. J Acquir Immune Defic Syndr 2004; 35 (3): 261-268
17. Mannheimer S, Friedland G, Matts J, Child C, Chesney M. The Consistency of Adherence to Antiretroviral Therapy Predicts Biologic Outcomes for Human Immunodeficiency Virus-Infected Persons in Clinical Trials. Clin Infec Dis 2002; 34:1115-21
18. Nachega J, Hislop M, Dowdy D, Chaisson R, Regensberg L, Maartens G. Effect of NNRTI-Based HIV Therapy Adherence on HIV-1 RNA. Ann Intern Med. 2007; 146:564-573.
19. Rigueira A. Cumplimiento terapéutico: ¿Qué conocemos en España? Aten Primaria 2001;27:559-568
20. Chesney MA, Ickovics JR, Chambers DB, Gifford AL, Neidig J, Zwickl B et al. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG Adherence instruments. AIDS Care 2000;12(3):255-266
21. Spire B, Duran S, Souville M, Leport C, Raffi F, Moatti J. Adherence to highly active antirretroviral therapies (HAART) in HIV-infected patients: from a predictive to a dynamic approach. SOC SCI MED 2002; 54:1481-1496.
22. Pegueró E, Zorat M, Gené J. Cumplimiento y entrevista terapéutica. Med Clin (Barc) 2001;116(sup2):52-55
23. Bland JM, Altman DG. Cronbach's alpha. BMJ. 1997; 314: 572.
24. Comín Bertrán E. Validación de encuestas. Aten Primaria 1990;7(5): 68-72
25. Hyland ME. A brief guide to the selection of quality of life instrument. Health Qual Life Outcomes 2003, 1:24
26. Wiebe S, Guyatt G, Weaver B, Matijevic S, Sidwell C. Comparative responsiveness of generic and specific quality-of-life instruments. J Clin Epidemiol. 2003; 56(1): 52-60.
27. Terwee CB, Dekker FW, Wiersinga WM, Prummel MF, Bossuyt PM. On assessing responsiveness of health-related quality of life instruments: Guidelines for instrument evaluation. Qual Life Res 2003; 12: 349-362.
28. Remor E. Valoración de la adhesión al tratamiento antirretroviral en pacientes VIH+. Psicothema 2002;14(3):262-267
29. Remor E. Manual del Cuestionario para la Evaluación de la Adhesión al Tratamiento Antirretroviral (CEAT-VIH). Versión 1.0, Madrid, 2002.
30. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. January 29, 2008. Available at http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL. pdf. Acceso: Febrero 2008.
31. Bell DJ, Kapitao Y, Sikwese R, van Oosterhout JJ, Lalloo DG. Adherence to antiretroviral therapy in patients receiving free treatment from a government hospital in Blantyre, Malawi. J Acquir Immune Defic Syndr. 2007 Aug 15; 45(5):560-3
32. Duong M, Piroth L, Grappin M, Forte F, Peytavin G, Buisson M, Chavanet P, Portier H. Evaluation of the Patient Medication Adherence Questionnaire as a tool for self-reported adherence assessment in HIV-infected patients on antiretroviral regimens. HIV Clin Trials. 2001 Mar-Apr; 2(2):128-35.
33. Muñoz-Moreno JA, Fumaz CR, Ferrer MJ, Tuldrà A, Rovira T, et al. Assessing self-reported adherence to HIV therapy by questionnaire: the SERAD (Self-Reported Adherence) Study. AIDS Res Hum Retroviruses. 2007; 23(10):1166-75.
34. Gallo FJ et al. Manual del Residente de Medicina Familiar y Comunitaria. Ed Barcelona, 1993.pp733.
35. Sherr L, Lampe F, Norwood S, Leake Date H, Harding R, Johnson M, Edwards S, Fisher M, Arthur G, Zetler S, Anderson J. Adherence to antiretroviral treatment in patients with HIV in the UK: a study of complexity. AIDS Care. 2008 Apr;20(4):442-8
36. Nilsson Schönnesson L, Diamond PM, Ross MW, Williams M, Bratt G. Baseline predictors of three types of antiretroviral therapy (ART) adherence: A 2-year follow-up. AIDS Care. 2006 May;18(4):407-14
37. Johnson MO, Chesney MA, Goldstein RB, Remien RH, Catz S, Gore-Felton C, Charlebois E, Morin SF. Positive provider interactions, adherence self-efficacy, and adherence to antiretroviral medications among HIV-infected adults: A mediation model. AIDS Patient Care STDS. 2006; 20(4):258-68.
38. oEdición
39. Remor E, Milner-Moskovics J, Preussler G. Adaptação brasileira do "Cuestionario para la Evaluación de la Adhesión al Tratamiento Antiretroviral" Rev Saúde Pública 2007;41(5)
40. Knobela H, Alonsob J, Casadoc J, Collazos J, Gonzalez J, Ruiz I, et al. Validation of a simplified medication adherence questionnaire in a large cohort of HIV-infected patients: the GEEMA Study. AIDS 2002, 16:605-613.